UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029046
Receipt No. R000033223
Official scientific title of the study The retrospective study of inhibitory effect on optic disc hemorrhage of anti glaucoma drugs
Date of disclosure of the study information 2017/09/07
Last modified on 2017/09/07 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The retrospective study of inhibitory effect on optic disc hemorrhage of anti glaucoma drugs
Title of the study (Brief title) Inhibitory effect of anti glaucoma drugs on optic disc hemorrhage
Region
Japan

Condition
Condition Glaucoma
Classification by specialty
Ophthalmology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This retrospective study aims to evaluate the effect of anti glaucoma drugs excluded 0.1% brimonidine on optic disc hemorrhage(DH) in the glaucoma patients with a history of DH.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Comparison with the frequency of DH before and after addition of anti glaucoma ophthalmic solution
Key secondary outcomes 1) Ratio of frequency of DH occurence
2) Intraocular pressure with Goldmann applanation tonometer

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Patients being treated for more than two years.
2)Patients administered with additional anti glaucoma ophthalmic solution for more than one year.
3)Patients with optic disc hemorrhage before administration of additional anti glaucoma ophthalmic solution
4)Patients who had no addition or change with glaucoma therapeutic drugs in the peroid between the day of anti glaucoma ophthalmic solution addition and the end date of observation period. (If both eyes constitute indication, worse eye is chosen.)
Key exclusion criteria 1)Patients with retinal disease.
2)Patients with corneal opacity.
3)Patients who underwent LASIK surgery.
4)Patients who are undergoing glaucoma surgery within the observation period since the addition of anti glaucoma ophthalmic solution
5) Patients who were inability to take visual field test in accuracy 6)Patients with MD value -25dB or below.
Target sample size 40

Research contact person
Name of lead principal investigator Koji Nitta
Organization Fukui-ken Saiseikai Hospital
Division name Ophthalmology
Address Funabashi7-1, Wadanakamachi, Fukui city, Fukui
TEL 0776-23-1111
Email nitta.koji7001@fukui.saiseikai.or.jp

Public contact
Name of contact person Koji Nitta
Organization Fukui-ken Saiseikai Hospital
Division name Ophthalmology
Address Funabashi7-1, Wadanakamachi, Fukui city, Fukui
TEL 0776-23-1111
Homepage URL
Email nitta.koji7001@fukui.saiseikai.or.jp

Sponsor
Institute Fukui-ken Saiseikai Hospital
Institute
Department

Funding Source
Organization Senju Pharmaceutical Co.,Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Shimamoto Ophthalmology Clinic (Fukui)
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 福井県済生会病院 島本眼科医院 Fukui-ken Saiseikai Hospital Shimamoto Ophthalmology Clinic (Fukui)

Other administrative information
Date of disclosure of the study information
2017 Year 09 Month 07 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 11 Month 18 Day
Anticipated trial start date
2016 Year 12 Month 14 Day
Last follow-up date
2017 Year 04 Month 24 Day
Date of closure to data entry
2017 Year 07 Month 03 Day
Date trial data considered complete
2017 Year 07 Month 28 Day
Date analysis concluded
2017 Year 08 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information nothing

Management information
Registered date
2017 Year 09 Month 07 Day
Last modified on
2017 Year 09 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033223